ATE372121T1 - Nicht fermentiertes gelanteil aus samenhülsen von psyllium - Google Patents

Nicht fermentiertes gelanteil aus samenhülsen von psyllium

Info

Publication number
ATE372121T1
ATE372121T1 AT00941266T AT00941266T ATE372121T1 AT E372121 T1 ATE372121 T1 AT E372121T1 AT 00941266 T AT00941266 T AT 00941266T AT 00941266 T AT00941266 T AT 00941266T AT E372121 T1 ATE372121 T1 AT E372121T1
Authority
AT
Austria
Prior art keywords
psyllium seed
seed hulls
gel portion
gel
fermented
Prior art date
Application number
AT00941266T
Other languages
English (en)
Inventor
Judith Marlett
Milton Fischer
Original Assignee
Wisconsin Alumni Res Found
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Wisconsin Alumni Res Found filed Critical Wisconsin Alumni Res Found
Application granted granted Critical
Publication of ATE372121T1 publication Critical patent/ATE372121T1/de

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
    • A61K36/18—Magnoliophyta (angiosperms)
    • A61K36/185—Magnoliopsida (dicotyledons)
    • A61K36/68—Plantaginaceae (Plantain Family)
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A61P1/10—Laxatives
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A61P3/06—Antihyperlipidemics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system

Landscapes

  • Health & Medical Sciences (AREA)
  • Natural Medicines & Medicinal Plants (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Veterinary Medicine (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Public Health (AREA)
  • Engineering & Computer Science (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • Epidemiology (AREA)
  • Microbiology (AREA)
  • Mycology (AREA)
  • Medical Informatics (AREA)
  • Botany (AREA)
  • Alternative & Traditional Medicine (AREA)
  • Biotechnology (AREA)
  • Hematology (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Obesity (AREA)
  • Cardiology (AREA)
  • Diabetes (AREA)
  • Medicines Containing Plant Substances (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Jellies, Jams, And Syrups (AREA)
  • Steroid Compounds (AREA)
  • Pretreatment Of Seeds And Plants (AREA)
  • Polysaccharides And Polysaccharide Derivatives (AREA)
  • Compositions Of Macromolecular Compounds (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
AT00941266T 1999-06-09 2000-06-08 Nicht fermentiertes gelanteil aus samenhülsen von psyllium ATE372121T1 (de)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US09/328,611 US6287609B1 (en) 1999-06-09 1999-06-09 Unfermented gel fraction from psyllium seed husks

Publications (1)

Publication Number Publication Date
ATE372121T1 true ATE372121T1 (de) 2007-09-15

Family

ID=23281664

Family Applications (1)

Application Number Title Priority Date Filing Date
AT00941266T ATE372121T1 (de) 1999-06-09 2000-06-08 Nicht fermentiertes gelanteil aus samenhülsen von psyllium

Country Status (12)

Country Link
US (2) US6287609B1 (de)
EP (1) EP1189621B1 (de)
JP (2) JP4034564B2 (de)
CN (2) CN100360136C (de)
AT (1) ATE372121T1 (de)
AU (1) AU773580B2 (de)
CA (1) CA2376326C (de)
DE (1) DE60036282T2 (de)
HK (1) HK1044718B (de)
MX (1) MXPA01012581A (de)
RU (2) RU2261102C2 (de)
WO (1) WO2000074689A1 (de)

Families Citing this family (70)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6946152B1 (en) 1999-06-09 2005-09-20 Wisconsin Alumni Research Foundation Unfermented gel fraction from psyllium seed husks
US6287609B1 (en) 1999-06-09 2001-09-11 Wisconsin Alumni Research Foundation Unfermented gel fraction from psyllium seed husks
WO2002030439A1 (en) * 2000-10-13 2002-04-18 E-Z-Em, Inc. A nutritional dietary system, formulation, kit and method for use in preparing an individual for a predetermined activity
EG26979A (en) * 2000-12-21 2015-03-01 Astrazeneca Ab Chemical compounds
GB0121337D0 (en) 2001-09-04 2001-10-24 Astrazeneca Ab Chemical compounds
GB0121621D0 (en) * 2001-09-07 2001-10-31 Astrazeneca Ab Chemical compounds
GB0121622D0 (en) 2001-09-07 2001-10-31 Astrazeneca Ab Chemical compounds
AU2002329387B2 (en) 2001-09-08 2007-06-07 Albireo Ab Benzothiazepine and benzothiadiazepine derivatives with ileal bile acid transport (IBAT) inhibitory activity for the treatment hyperlipidaemia
US7195789B2 (en) * 2002-03-07 2007-03-27 Board Of Trustees Of Michigan State University Non-fiber extract of psyllium with anti-tumorigenic effects and method for identifying the same
US9980988B2 (en) 2002-03-13 2018-05-29 Kibow Biotech, Inc. Compositions and methods for augmenting kidney function
US9655932B2 (en) 2002-03-13 2017-05-23 Kibow Biotech, Inc. Composition and method for preventing or treating gout or hyperuricemia
US20050074442A1 (en) 2002-03-13 2005-04-07 Natarajan Ranganathan Compositions and methods for augmenting kidney function
US11103542B2 (en) 2002-03-13 2021-08-31 Kibow Biotech, Inc. Composition and method for maintaining healthy kidney function
JP2003278418A (ja) * 2002-03-22 2003-10-02 Denso Corp 車載無線機装置
GB0209467D0 (en) 2002-04-25 2002-06-05 Astrazeneca Ab Chemical compounds
US7014862B2 (en) * 2002-05-20 2006-03-21 The Procter & Gamble Company Chewable compositions containing a gel-forming extract of psyllium
US20030215534A1 (en) * 2002-05-20 2003-11-20 The Procter & Gamble Company Extraction of unmilled psyllium
US20050042307A1 (en) * 2002-05-21 2005-02-24 Marlett Judith A. Gel-forming polysaccharide from psyllium seed husks
GB0213669D0 (en) * 2002-06-14 2002-07-24 Astrazeneca Ab Chemical compounds
GB0216321D0 (en) * 2002-07-13 2002-08-21 Astrazeneca Ab Therapeutic treatment
US6982254B2 (en) * 2003-02-18 2006-01-03 The Procter & Gamble Company Compositions comprising a plurality of particles or agglomerates having a defined particle size
US7098193B2 (en) * 2003-02-18 2006-08-29 The Procter & Gamble Company Compositions comprising a defined polysaccharide component
US7026303B2 (en) * 2003-02-18 2006-04-11 The Procter & Gamble Company Compositions comprising a polysaccharide component and one or more coating layers
US20040161471A1 (en) * 2003-02-18 2004-08-19 Cimiluca Paul Alfred Compositions comprising a plurality of particles or agglomerates having a defined particle size
GB0304194D0 (en) * 2003-02-25 2003-03-26 Astrazeneca Ab Chemical compounds
GB0307918D0 (en) * 2003-04-05 2003-05-14 Astrazeneca Ab Therapeutic use
AU2008202120B2 (en) * 2003-04-05 2009-12-17 Albireo Ab Use of an IBAT inhibitor for the treatment of prophylaxis of constipation
US20050250734A1 (en) * 2003-11-07 2005-11-10 The Procter & Gamble Company Compositions, kits, and methods for the treatment of conditions associated with elevated cholesterol levels
US7106595B2 (en) * 2004-09-15 2006-09-12 International Business Machines Corporation Apparatus including a thermal bus on a circuit board for cooling components on a daughter card releasably attached to the circuit board
US20060165824A1 (en) * 2005-01-26 2006-07-27 The Procter & Gamble Company Compositions, kits, and methods for enhancing gastrointestinal health
US9420807B2 (en) * 2007-04-02 2016-08-23 Purina Animal Nutrition Llc Method of feeding young monogastric mammals and composition fed to young monogastric mammals
US20080293670A1 (en) * 2007-05-23 2008-11-27 Agricultural Research Institute Edible tremella polysaccharide for prevention and/or improvement of intestinal disorder
JP5390091B2 (ja) * 2007-12-05 2014-01-15 矢崎総業株式会社 コネクタ
WO2018129556A1 (en) 2017-01-09 2018-07-12 Ardelyx, Inc. Compounds and methods for inhibiting nhe-mediated antiport in the treatment of disorders associated with fluid retention or salt overload and gastrointestinal tract disorders
MX381407B (es) 2008-12-31 2025-03-12 Ardelyx Inc Compuestos y métodos para inhibir el antiporte mediado por intercambiador de iones de sodio/iones de hidrógeno (nhe) en el tratamiento de trastornos asociados con retención de fluido o sobrecarga de sal y trastornos del tracto gastrointestinal.
US20100278949A1 (en) * 2009-05-01 2010-11-04 Jeffery Dale Scott Pre-procedure meal regimen
ES2687027T3 (es) 2010-11-04 2018-10-23 Albireo Ab Inhibidores de ibat para el tratamiento de enfermedades hepáticas
MX366293B (es) 2012-08-21 2019-07-04 Ardelyx Inc Compuestos y metodos para inhibir al antipuerto mediado por nhe en el tratamiento de trastornos asociados con la retencion de fluidos o la sobrecarga de sal y trastornos del tracto gastrointestinal.
US10376481B2 (en) 2012-08-21 2019-08-13 Ardelyx, Inc. Compounds and methods for inhibiting NHE-mediated antiport in the treatment of disorders associated with fluid retention or salt overload and gastrointestinal tract disorders
HRP20191000T1 (hr) 2013-04-12 2019-09-20 Ardelyx, Inc. Spojevi za vezanje nhe3 i metode inhibiranja transporta fosfata
JO3301B1 (ar) 2013-04-26 2018-09-16 Albireo Ab تعديلات بلورية على إيلوبيكسيبات
CN106659726A (zh) 2014-06-25 2017-05-10 Ea制药株式会社 固体制剂及其着色防止或着色减少方法
EP3012252A1 (de) 2014-10-24 2016-04-27 Ferring BV Kristalline Form von elobixibat
JP6698286B2 (ja) * 2015-07-06 2020-05-27 シキボウ株式会社 サイリウムシードガムの製造方法及びサイリウムシードガム
US10226063B2 (en) 2015-10-01 2019-03-12 The United States Of America As Represented By The Secretary Of Agriculture Methods of decreasing the viscosity of a dietary fiber
ES2874669T3 (es) 2016-02-09 2021-11-05 Albireo Ab Formulación oral de colestiramina y uso de la misma
WO2017138878A1 (en) 2016-02-09 2017-08-17 Albireo Ab Oral cholestyramine formulation and use thereof
CN108601739B (zh) 2016-02-09 2022-01-04 阿尔比里奥公司 考来烯胺丸剂及其制备方法
US11179426B2 (en) 2016-12-29 2021-11-23 Kibow Biotech, Inc. Composition and method for maintaining healthy kidney function
MX2019008171A (es) 2017-01-09 2020-02-05 Ardelyx Inc Inhibidores del antiporte mediado por nhe.
MX395405B (es) 2017-01-09 2025-03-25 Ardelyx Inc Compuestos útiles para tratar trastornos del tracto gastrointestinal.
CN111032019B (zh) 2017-08-09 2022-07-05 阿尔比里奥公司 考来烯胺颗粒、口服考来烯胺制剂及其用途
CN112449637B (zh) 2018-06-05 2024-03-19 阿尔比里奥公司 苯并硫杂(二)氮杂环庚三烯化合物及其作为胆汁酸调节剂的用途
US11801226B2 (en) 2018-06-20 2023-10-31 Albireo Ab Pharmaceutical formulation of odevixibat
PL3810581T3 (pl) 2018-06-20 2025-04-28 Albireo Ab Modyfikacje kryształu odewiksibatu
US11007142B2 (en) 2018-08-09 2021-05-18 Albireo Ab Oral cholestyramine formulation and use thereof
US11549878B2 (en) 2018-08-09 2023-01-10 Albireo Ab In vitro method for determining the adsorbing capacity of an insoluble adsorbant
US10722457B2 (en) 2018-08-09 2020-07-28 Albireo Ab Oral cholestyramine formulation and use thereof
TWI835997B (zh) 2019-02-06 2024-03-21 瑞典商艾爾比瑞歐公司 苯并噻氮呯化合物及其用作膽酸調節劑之用途
CN118852054A (zh) 2019-02-06 2024-10-29 阿尔比里奥公司 苯并硫杂二氮杂环庚三烯化合物及其用作胆汁酸调节剂的用途
ES2973355T3 (es) 2019-12-04 2024-06-19 Albireo Ab Compuestos de benzotia(di)azepina y su uso como moduladores del ácido biliar
EP4069247B1 (de) 2019-12-04 2025-03-26 Albireo AB Benzothiadiazepinverbindungen und ihre verwendung als gallensäuremodulatoren
JP7696898B2 (ja) 2019-12-04 2025-06-23 アルビレオ・アクチボラグ ベンゾチア（ジ）アゼピン化合物及び胆汁酸モジュレータとしてのそれらの使用
US11014898B1 (en) 2020-12-04 2021-05-25 Albireo Ab Benzothiazepine compounds and their use as bile acid modulators
IL293379B2 (en) 2019-12-04 2026-04-01 Albireo Ab Benzothia(dia)azepine compounds and their use as bile acid modulators
EP4188541B1 (de) 2020-08-03 2024-12-25 Albireo AB Benzothia(di)azepin-verbindungen und ihre verwendung als gallensäuremodulatoren
CA3196488A1 (en) 2020-11-12 2022-05-19 Albireo Ab Odevixibat for treating progressive familial intrahepatic cholestasis (pfic)
BR112023010799A2 (pt) 2020-12-04 2023-10-03 Albireo Ab Compostos de benzotia(di)azepina e seus usos como moduladores de ácidos biliares
TW202313579A (zh) 2021-06-03 2023-04-01 瑞典商艾爾比瑞歐公司 苯并噻(二)氮呯(benzothia(di)azepine)化合物及其作為膽酸調節劑之用途
CN114343099B (zh) * 2022-01-11 2024-03-26 山东中大药业有限公司 一种l-阿拉伯糖膳食纤维固体饮料及其制备方法

Family Cites Families (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
RU2008771C1 (ru) * 1986-07-25 1994-03-15 Арко Кемикал Компани Низкокалорийный пищевой продукт
MX168010B (es) * 1987-01-06 1993-04-28 Felipe Salete Procedimiento mejorado para la obtencion de mucilago de plantogo psyllium de alta pureza
NL9001980A (nl) * 1990-09-07 1992-04-01 Pharmalett Int Bv Toepassing van polysacchariden in preparaten voor wondbehandeling.
US5248502A (en) * 1991-11-08 1993-09-28 Kellogg Company Method for decreasing the allergenicity of psyllium seed husk by alkaline treatment
US5234916A (en) * 1992-06-12 1993-08-10 The Proctor & Gamble Company Psyllium drink mix compositions
US5422101A (en) * 1993-05-14 1995-06-06 The Procter & Gamble Company Cholesterol lowering drink mix compositions
RU2112525C1 (ru) * 1995-07-20 1998-06-10 Институт хирургии Восточно-сибирского научного центра СО РАМН Средство для коррекции гиперлипидемии
US6287609B1 (en) 1999-06-09 2001-09-11 Wisconsin Alumni Research Foundation Unfermented gel fraction from psyllium seed husks

Also Published As

Publication number Publication date
DE60036282T2 (de) 2008-06-05
WO2000074689A1 (en) 2000-12-14
CN1365283A (zh) 2002-08-21
CA2376326C (en) 2011-03-15
AU5599400A (en) 2000-12-28
RU2314114C2 (ru) 2008-01-10
EP1189621A4 (de) 2004-05-26
JP2008013575A (ja) 2008-01-24
US6676979B2 (en) 2004-01-13
AU773580B2 (en) 2004-05-27
CN101219165A (zh) 2008-07-16
JP4034564B2 (ja) 2008-01-16
WO2000074689A8 (en) 2001-06-21
HK1044718B (en) 2008-04-25
RU2261102C2 (ru) 2005-09-27
CN100360136C (zh) 2008-01-09
CA2376326A1 (en) 2000-12-14
EP1189621B1 (de) 2007-09-05
RU2005102049A (ru) 2006-07-10
HK1044718A1 (en) 2002-11-01
DE60036282D1 (de) 2007-10-18
JP2003505436A (ja) 2003-02-12
US20020142054A1 (en) 2002-10-03
MXPA01012581A (es) 2002-04-10
EP1189621A1 (de) 2002-03-27
US6287609B1 (en) 2001-09-11

Similar Documents

Publication Publication Date Title
ATE372121T1 (de) Nicht fermentiertes gelanteil aus samenhülsen von psyllium
DE60010098D1 (de) 28-epirapaloge
AR010062A1 (es) Nuevos benzamidaldehidos y su utilizacion
HN1996000017A (es) Isotiazolonas
MA24643A1 (fr) Tetrahydro-naphtalenes substitues et composes analogues
TR200002773T2 (tr) Alzheimer tedavisi için smilagenin ve anzurogenin-D ve bunların kullanımı.
DK0944643T3 (da) Oxyiminopregnancarbolactoner.
DE69826684D1 (de) Kovalent gebundenes n,o-carboxymethylchitosan und seine verwendungen
ATE255153T1 (de) Integriertes lösungsmittelentasphaltierungs- , vergasungs- und wasserstoffbehandlungsverfahren
WO2000066528A3 (en) Quinones for treatment of diseases
DK1066291T3 (da) Svampedræbende 6-(2-halogen-4-alkoxyphenyl)-triazolopyrimidiner
AU4996100A (en) (s,r) formoterol methods and compositions
TR200001102T2 (tr) İkameli tetrahidropirimidinen türevleri, üretimleri ve kullanımları.
PT1204659E (pt) Benzofuranos serotoninergicos
ITMI20000665A0 (it) Glicosaminoglicani derivati dal polisaccaride k5 aventi elevata attivita' anticoagulante ed antitrombotica e processo per la loro preparazio
BG100248A (bg) Инхибитори на скваленсинтетаза
TR200200278T2 (tr) Kalsilitik bileşimler
UY26085A1 (es) N-[-(4-aminofenil)-2,3-dihidro-1,4-benzodioxina-2-metanamina su preparacion y su aplicacion en terapeutica
PT1244643E (pt) Inibidores da triptase
SI1244614T1 (en) Tryptase inhibitors
DE4092406A1 (de)
ID27733A (id) Metoksiminofenilasetamida
DE50003587D1 (de) Verbundelemente
MA23574A1 (fr) Nouveaux derives alcanes 1,1-bis (heteroazolyl) et leur utilisation comme agents neuro-inhibiteurs
PL354683A1 (pl) Sieciowy system adresowania i sposób wykorzystywania numerów telefonicznych

Legal Events

Date Code Title Description
RER Ceased as to paragraph 5 lit. 3 law introducing patent treaties